OBJECTIVE: We first tested the brain reserve (BR) hypothesis in multiple sclerosis (MS) by examining whether larger maximal lifetime brain volume (MLBV; determined by genetics) protects against disease-related cognitive impairment, and then investigated whether cognitive reserve (CR) gained through life experience (intellectually enriching leisure activities) protects against cognitive decline independently of MLBV (BR). METHODS: Sixty-two patients with MS (41 relapsing-remitting MS, 21 secondary progressive MS) received MRIs to estimate BR (MLBV, estimated with intracranial volume [ICV]) and disease burden (T2 lesion load; atrophy of gray matter, white matter, thalamus, and hippocampus). Early-life cognitive leisure was measured as a source of CR. We assessed cognitive status with tasks of cognitive efficiency and memory. Hierarchical regressions were used to investigate whether higher BR (ICV) protects against cognitive impairment, and whether higher CR (leisure) independently protects against cognitive impairment over and above BR. RESULTS: Cognitive status was positively associated with ICV (R(2) = 0.066, p = 0.017). An ICV × disease burden interaction (R(2) = 0.050, p = 0.030) revealed that larger ICV attenuated the impact of disease burden on cognition. Controlling for BR, higher education (R(2) = 0.047, p = 0.030) and leisure (R(2) = 0.090, p = 0.001) predicted better cognition. A leisure × disease burden interaction (R(2) = 0.037, p = 0.030) showed that leisure independently attenuated the impact of disease burden on cognition. Follow-up analyses revealed that BR protected against cognitive inefficiency, not memory deficits, whereas CR was more protective against memory deficits than cognitive inefficiency. CONCLUSION: We provide evidence of BR in MS, and show that CR independently protects against disease-related cognitive decline over and above BR. Lifestyle choices protect against cognitive impairment independently of genetic factors outside of one's control.
OBJECTIVE: We first tested the brain reserve (BR) hypothesis in multiple sclerosis (MS) by examining whether larger maximal lifetime brain volume (MLBV; determined by genetics) protects against disease-related cognitive impairment, and then investigated whether cognitive reserve (CR) gained through life experience (intellectually enriching leisure activities) protects against cognitive decline independently of MLBV (BR). METHODS: Sixty-two patients with MS (41 relapsing-remitting MS, 21 secondary progressive MS) received MRIs to estimate BR (MLBV, estimated with intracranial volume [ICV]) and disease burden (T2 lesion load; atrophy of gray matter, white matter, thalamus, and hippocampus). Early-life cognitive leisure was measured as a source of CR. We assessed cognitive status with tasks of cognitive efficiency and memory. Hierarchical regressions were used to investigate whether higher BR (ICV) protects against cognitive impairment, and whether higher CR (leisure) independently protects against cognitive impairment over and above BR. RESULTS: Cognitive status was positively associated with ICV (R(2) = 0.066, p = 0.017). An ICV × disease burden interaction (R(2) = 0.050, p = 0.030) revealed that larger ICV attenuated the impact of disease burden on cognition. Controlling for BR, higher education (R(2) = 0.047, p = 0.030) and leisure (R(2) = 0.090, p = 0.001) predicted better cognition. A leisure × disease burden interaction (R(2) = 0.037, p = 0.030) showed that leisure independently attenuated the impact of disease burden on cognition. Follow-up analyses revealed that BR protected against cognitive inefficiency, not memory deficits, whereas CR was more protective against memory deficits than cognitive inefficiency. CONCLUSION: We provide evidence of BR in MS, and show that CR independently protects against disease-related cognitive decline over and above BR. Lifestyle choices protect against cognitive impairment independently of genetic factors outside of one's control.
Authors: Bogdan Draganski; Christian Gaser; Gerd Kempermann; H Georg Kuhn; Jürgen Winkler; Christian Büchel; Arne May Journal: J Neurosci Date: 2006-06-07 Impact factor: 6.167
Authors: D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson Journal: Neurology Date: 2006-06-27 Impact factor: 9.910
Authors: E Mori; N Hirono; H Yamashita; T Imamura; Y Ikejiri; M Ikeda; H Kitagaki; T Shimomura; Y Yoneda Journal: Am J Psychiatry Date: 1997-01 Impact factor: 18.112
Authors: J F Sumowski; M A Rocca; V M Leavitt; G Riccitelli; J Sandry; J DeLuca; G Comi; M Filippi Journal: Eur J Neurol Date: 2015-02-04 Impact factor: 6.089
Authors: Lorenzo Conti; Gianna C Riccitelli; Paolo Preziosa; Carmen Vizzino; Olga Marchesi; Maria A Rocca; Massimo Filippi Journal: J Neurol Date: 2021-01-02 Impact factor: 4.849
Authors: John Dominic Medaglia; Fabio Pasqualetti; Roy H Hamilton; Sharon L Thompson-Schill; Danielle S Bassett Journal: Neurosci Biobehav Rev Date: 2017-01-16 Impact factor: 8.989
Authors: Markus D Schirmer; Mark R Etherton Md PhD; Adrian V Dalca PhD; Anne-Katrin Giese Md; Lisa Cloonan MSc; Ona Wu PhD; Polina Golland PhD; Natalia S Rost Md Mph Faan Journal: J Stroke Cerebrovasc Dis Date: 2018-09-28 Impact factor: 2.136
Authors: James F Sumowski; Maria A Rocca; Victoria M Leavitt; Gianna Riccitelli; Alessandro Meani; Giancarlo Comi; Massimo Filippi Journal: Mult Scler Date: 2016-02-26 Impact factor: 6.312